ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 459

$709K Total Retail Price of All Prescriptions

Rank: 12 out of 459

583 Patients Receiving at Least One Drug in Part D
36%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,236 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
METFORMIN HCL 644 246 1 7
SIMVASTATIN 563 261 2 1
LISINOPRIL 520 216 3 4
AMLODIPINE BESYLATE 460 272 4 6
OMEPRAZOLE 449 143 5 3
PRAVASTATIN SODIUM 402 196 6 12
HYDROCHLOROTHIAZIDE 366 169 7 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 307 114 8 21
FUROSEMIDE 294 129 9 8
TRAMADOL HCL 286 57 10 13
TRAZODONE HCL 283 48 11 26
METOPROLOL TARTRATE 274 106 12 11
CARVEDILOL 268 162 13 23
MELOXICAM 262 114 14 34
LEVOTHYROXINE SODIUM 230 86 15 5
GABAPENTIN 207 66 16 10
NEXIUM 187 62 17 16
NIFEDIPINE ER 177 112 18 139
LOSARTAN POTASSIUM 172 98 19 22
LOSARTAN-HYDROCHLOROTHIAZIDE 160 81 20 49
PROAIR HFA 143 49 21 32
CRESTOR 142 55 22 31
DIOVAN 121 56 23 59
DICLOFENAC SODIUM 118 27 24 103
LOVASTATIN 117 53 25 37
FLUTICASONE PROPIONATE 114 46 26 36
ZETIA 114 24 26 62
ESCITALOPRAM OXALATE 110 30 28 61
NAPROXEN 110 49 28 104
CITALOPRAM HBR 101 38 30 18
ATORVASTATIN CALCIUM 101 56 30 15
CYMBALTA 94 0 32 35
METFORMIN HCL ER 93 33 33 43
GLIMEPIRIDE 90 46 34 39
DIOVAN HCT 90 41 34 72
CLOPIDOGREL 88 46 36 55
ADVAIR DISKUS 88 23 36 53
ATENOLOL 86 42 38 14
TRIAMTERENE-HCTZ 84 51 39 83
SERTRALINE HCL 84 28 39 20
PLAVIX 84 46 39 89
BUSPIRONE HCL 83 0 42 105
NOVOLOG MIX 70-30 83 34 42 221
KLOR-CON M20 81 48 44 92
CLONIDINE HCL 80 22 45 60
SINGULAIR 76 22 46 66
PANTOPRAZOLE SODIUM 75 20 47 38
GEMFIBROZIL 74 12 48 109
GLIPIZIDE ER 74 52 48 126
ACTOS 72 26 50 192
SPIRIVA 69 12 51 45
LEVEMIR FLEXPEN 64 11 52 248
LANTUS 63 29 53 81
GLIPIZIDE 61 25 54 51
RANITIDINE HCL 58 17 55 29
LORATADINE 57 12 56 176
COLCRYS 55 39 57 269
SPIRONOLACTONE 55 21 57 56
CYCLOBENZAPRINE HCL 52 0 R 59 41
FAMOTIDINE 52 18 59 116
PAROXETINE HCL 51 23 61 58
PHENYTOIN SODIUM EXTENDED 51 23 61 138
FLUOXETINE HCL 51 19 61 47
JANUVIA 50 32 64 69
INSULIN SYRINGE 50 21 64 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.